THE management of genetic blood disorders such as Thalassemia and Sickle Cell Anaemia across Madhya Pradesh represents a complex interplay between public healthcare delivery and deeply embedded social dynamics. While operational shortcomings within health departments present ongoing administrative challenges, community silence, social taboos and a lack of public awareness continue to exacerbate the burden of these hereditary conditions. In the densely forested tribal regions of eastern Madhya Pradesh specifically across districts such as Shahdol, Anuppur, Dindori and Alirajpur sickle cell trait and thalassemia have historically exerted a profound toll on generational health. In a telephonic interview with The Hitavada, Dr Ruby Khan, Deputy Director of the Blood Cell unit at the National Health Mission (NHM), Bhopal, outlined the State’s ongoing transition from reactive medical interventions to a unified, long-term strategy centered on active screening, genetic counseling and systemic eradication. Dr Khan shared, “A central element of this institutional overhaul is the establishment of a specialised Department of Haemoglobinopathy under NHM Madhya Pradesh. MP secured the top position nationwide under National Sickle Cell Anaemia Elimination Mission, having screened over 9 million individuals. To address diagnostic barriers in rural areas, public health infrastructure has integrated High-Performance Liquid Chromatography (HPLC) machinery into district-level hospitals. Serving as the primary confirmatory standard under State healthcare initiatives and the National Sickle Cell Anaemia Elimination Mission, these automated diagnostic units enable precise identification of haemoglobinopathies locally. By centralising HPLC technology at district facilities, the State has substantially reduced out-of-pocket diagnostic expenses for marginalised populations who previously depended on private laboratories or distant tertiary referral centres.

 

This localised access allows surrounding primary healthcare networks to utilise reference-grade testing while optimising capital equipment usage.” Dr Khanj further added, “On the ground, field delivery relies on mobile healthcare units comprising Auxiliary Nurse Midwives ( A N M s ) , Community H e a l t h O f f i c e r s (CHOs), and l a b o r a t o r y technicians. These teams conduct door-todoor screenings across interior villages, Anganwadi centres, and educational institutions utilising pointof-care solubility test kits and portable haemoglobin electrophoresis devices. A key objective of field screening is the premarital identification of prospective partners carrying the sickle haemoglobin gene (HbS) or thalassemia traits. Through systematic carrier mapping, public health counselors assist couples in making informed reproductive decisions, thereby curbing the genetic transmission of severe traits.” “This effort aligns with the National Sickle Cell Anaemia Elimination Mission, which was formally launched from Shahdol with a target timeline to eliminate transmission by 2047. However, establishing comprehensive point-of-care facilities for thalassemia across the entire State remains an active operational challenge”, accepted Dr Khan. She added that despite clinical progress, significant sociocultural hurdles impede early intervention. Misconceptions regarding genetic inheritance persist, frequently resulting in social ostracisation, emotional trauma and isolation for affected children and their families. Furthermore, widespread cultural practices such as concealing pregnancy during early trimesters due to fear of ill fortune, directly delay critical healthcare interactions. This delay prevents expectant couples from accessing timely prenatal genetic counseling and early-trimester diagnostic procedures like HPLC testing. As Dr Khan emphasised, medical treatments and clinical screening mechanisms cannot achieve sustained success in isolation. Eradicating systemic stigma through targeted public literacy campaigns, community-led genetic counseling and accessible carrier screening remains as fundamental to public health outcomes as direct clinical management.